mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Vitamin D deficiency, CD4+CD28null cells and Accelerated Atherosclerosis in Chronic Kidney Disease

Yadav AK et al. - Vitamin D deficiency, inflammatory activation and higher frequency of CD4+CD28null T lymphocyte population correlate with preclinical atherosclerotic changes in chronic kidney disease (CKD) population. These findings suggest possible linkage between vitamin D metabolism and T cell modulation, abnormalities which may contribution to development of atherosclerosis in CKD.

Methods
  • A total of of 101 stage 4-5 non-dialysis CKD patients and 40 healthy controls were studied.
  • Common carotid artery intima media thickness (CCA-IMT) was measured with an ultrasound system.
  • 25(OH) vitamin D and highly sensitive C-reactive protein (hsCRP) were measured in serum by ELISA.

Results
  • The frequency of circulating CD4+CD28null cells was evaluated by flowcytometry.
  • CKD subjects exhibited higher CCA-IMT (0.71±0.01 v 0.56±0.01 mm, p<0.0001), hsCRP (90.7±5.8 v 50.1±8.6 µg/ml, p<0.0001), CD4+CD28null cell frequency (9.1±0.9 v 3.6±0.5%, p<0.0001) and lower 25(OH) vitamin D levels (17.9±1.9 v 26.9±3.5 ng/ml, p<0.0001).
  • In CKD subjects, serum 25 (OH) vitamin D level showed a strong inverse correlation with CCA-IMT (r=-0.729, p<0.0001), and correlated with CD4+CD28null cell frequency (r=-0.249, p=0.01) and hsCRP (r=-0.2, p=0.047).
  • The authors also noted correlation of IMT with patient age (r=0.291, p=0.004) and CD4+CD28null cells (r=0.34, p=0.001).
  • On multiple regression analysis, 25(OH) vitamin D level, diabetic status and CD4+CD28null cell frequency exhibited independent association with IMT in CKD subjects.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close